A detailed history of Bank Of America Corp transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 174,659 shares of AMRX stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
174,659
Previous 536,062 67.42%
Holding current value
$1.37 Million
Previous $3.4 Million 57.3%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.42 - $8.83 $2.32 Million - $3.19 Million
-361,403 Reduced 67.42%
174,659 $1.45 Million
Q2 2024

Aug 14, 2024

BUY
$5.36 - $7.11 $1.69 Million - $2.24 Million
314,727 Added 142.19%
536,062 $3.4 Million
Q1 2024

May 15, 2024

BUY
$5.24 - $6.34 $205,973 - $249,212
39,308 Added 21.59%
221,335 $1.34 Million
Q4 2023

Feb 14, 2024

BUY
$3.36 - $6.21 $241,940 - $447,157
72,006 Added 65.45%
182,027 $1.1 Million
Q2 2023

Aug 14, 2023

SELL
$1.33 - $3.1 $21,234 - $49,494
-15,966 Reduced 12.67%
110,021 $341,000
Q1 2023

May 12, 2023

SELL
$1.27 - $2.7 $1.04 Million - $2.21 Million
-817,599 Reduced 86.65%
125,987 $175,000
Q4 2022

Feb 10, 2023

BUY
$1.96 - $2.61 $1.71 Million - $2.28 Million
873,690 Added 1249.99%
943,586 $1.88 Million
Q3 2022

Nov 14, 2022

SELL
$2.02 - $3.62 $167 - $300
-83 Reduced 0.12%
69,896 $141,000
Q2 2022

Aug 12, 2022

BUY
$3.01 - $4.46 $110,755 - $164,110
36,796 Added 110.89%
69,979 $222,000
Q1 2022

May 16, 2022

SELL
$3.9 - $4.89 $116,138 - $145,619
-29,779 Reduced 47.3%
33,183 $138,000
Q4 2021

Feb 08, 2022

BUY
$3.95 - $5.85 $87,429 - $129,483
22,134 Added 54.21%
62,962 $302,000
Q3 2021

Nov 15, 2021

BUY
$4.31 - $5.64 $19,976 - $26,141
4,635 Added 12.81%
40,828 $217,000
Q2 2021

Sep 13, 2021

BUY
$5.12 - $6.82 $185,308 - $246,836
36,193 New
36,193 $185,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.19B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.